Pierrepont Therapeutics
BROOKLYN, New York, United States · Biotechnology, Healthcare
Pierrepont Therapeutics, Inc. is dedicated to developing targeted treatments for primary mitochondrial and other rare genetic diseases. Pierrepont's lead product candidate, PTI-501 (formerly ENTR-501) is a proprietary intracellular enzyme replacement therapy for the treatment of MNGIE that is exclusively licensed from Entrada Therapeutics, Inc. (Nasdaq: TRDA). The founders of Pierrepont have uniqu
Key facts
- Headquarters
- BROOKLYN, New York, United States
- Employees
- 2
- Industries
- Biotechnology, Healthcare
- Status
- Private
- Website
- www.pierreponttx.com
- Company page
Recent activity at Pierrepont Therapeutics
Pierrepont Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Apr 2024 | Seed | $2.1M |
Leadership
- Matthew Wyckoff, Director
- Daniel DiPietro, Director
- Peter Barber, Executive Officer
Verified email and direct lines for Pierrepont Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Companies similar to Pierrepont Therapeutics
- Flyte · Biotechnology, Healthcare
- Coeurative, Inc. · Biotechnology, Healthcare
- Optimvia · Biotechnology, Healthcare
- Cirius Therapeutics · Biotechnology, Healthcare
- QView Medical · Biotechnology, Healthcare
About Pierrepont Therapeutics: questions and answers
What does Pierrepont Therapeutics do?
Pierrepont Therapeutics, Inc. is dedicated to developing targeted treatments for primary mitochondrial and other rare genetic diseases. Pierrepont's lead product candidate, PTI-501 (formerly ENTR-501) is a proprietary intracellular enzyme replacement therapy for the treatment of MNGIE that is exclusively licensed from Entrada Therapeutics, Inc. (Nasdaq: TRDA). The founders of Pierrepont have uniqu
Where is Pierrepont Therapeutics headquartered?
Pierrepont Therapeutics is headquartered in BROOKLYN, New York, United States.
How many employees does Pierrepont Therapeutics have?
Pierrepont Therapeutics has about 2 employees.
Has Pierrepont Therapeutics raised funding?
Yes. Fundz has recorded 1 funding event for Pierrepont Therapeutics. The most recent, Seed of $2.1M, was in Apr 2024.
What is the latest news on Pierrepont Therapeutics?
On Sep 22, 2026, Pierrepont Therapeutics
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy